First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Genex Services' IME Program Earns URAC designation
Company among first to receive new certification status for independent medical exams WAYNE, PA –
WorkCompWire: 5 Things You Should Know about IMEs and COVID-19
Though the COVID-19 pandemic has presented many challenges, workers’ compensation (WC) programs have continued to push claims forward – often with
Mitchell’s Q1 Industry Trends Report Examines the Ongoing Effects of COVID-19 and Implications for Property & Casualty Claims and Collision Repair
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the Property &
Workers’ Comp Data: About 25% of COVID-19 Claims Have Associated Medical Costs
Data analysis by Aarthi Thiruvengadam. In 2020, the workers’ compensation industry endured many changes due to the COVID-19 pandemic, incl
A Shot in the Arm to Move Claims Forward During COVID
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
As Crises Linger, U.S. Hospitals Continue to Face Headwinds
This article is authored by guest blogger, Jill Harris, Senior Director, Network Development at Coventry, a part of Mitchell | Genex | Coventry